These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1623115)

  • 1. Thrombonostika F1.2.
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):122. PubMed ID: 1623115
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of an enzyme-linked immunosorbent assay for the determination of prothrombin fragment F1.2 (Dade Prothrombin Fragment F1.2 ELISA: Baxter Diagnostics Inc., U.S.A.) using micro-titer plate].
    Suzuki T; Amano K; Kuroso K; Fukutake K; Fujimaki M
    Rinsho Byori; 1993 Feb; 41(2):215-9. PubMed ID: 8361024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization of commercial ELISA methods for the measurement of prothrombin fragment 1.2: is it feasible?
    D'Angelo A; Della Valle P; Calori G; Galli L; Vigano D'Angelo S
    Thromb Haemost; 1995 Mar; 73(3):548; author reply 549-50. PubMed ID: 7667841
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased prothrombin fragment 1.2 concentrations in hemodialysis patients.
    Erdem Y; Haznedaroğlu IC; Kiraz S
    Clin Nephrol; 1996 Jan; 45(1):69. PubMed ID: 8616963
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection.
    Hursting MJ; Slaughter TF; Stead AG; Szewczyk KM; Witt DJ; Greenberg CS
    Arch Pathol Lab Med; 1998 Jan; 122(1):31-6. PubMed ID: 9448013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prothrombin fragment F1 + 2].
    Kohlhaussen T
    Dtsch Med Wochenschr; 1993 Oct; 118(41):1504. PubMed ID: 8404515
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prothrombin (factor II) and fragment 1+2 (F1+2)].
    Maruyama I
    Nihon Rinsho; 1999 Sep; 57 Suppl():579-81. PubMed ID: 10543183
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease.
    Smith CJ; Haire WD; Kaufman SS; Mack DR
    Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulants: old drugs with a promising future.
    D'Angelo A; Crippa L; Agazzi A; Della Valle P; Anzalone N; Garlando AM; D'Angelo SV
    Haematologica; 1995; 80(2 Suppl):92-101. PubMed ID: 7628778
    [No Abstract]   [Full Text] [Related]  

  • 11. Species specificity of ELISAs for prothrombin fragment F1.2.
    Valdes-Camin R; Ebert RF
    Thromb Res; 1994 Sep; 75(6):657-62. PubMed ID: 7831685
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated prothrombin fragment 1 + 2 (F1 + 2) plasma levels may provide evidence of hypercoagulable states in gynecologic emergencies.
    Anand A
    Gynecol Oncol; 1994 Jul; 54(1):101. PubMed ID: 8020831
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Purification and characterization of activation fragments F1 and F2 from human prothrombin.
    Ball AP; Fenton J; Aronson DL; Franza RB; Young AM
    Thromb Diath Haemorrh; 1975 Nov; 34(2):591. PubMed ID: 1198504
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of laboratory tests in the diagnosis of venous thromboembolism.
    Sié P
    Haematologica; 1995; 80(2 Suppl):57-60. PubMed ID: 7628772
    [No Abstract]   [Full Text] [Related]  

  • 15. New trends in the field of coagulation diagnosis--new possibilities to improve monitoring of antithrombotic therapy.
    Pelzer H; Stüber W; Dati F; Heimburger N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):867-71. PubMed ID: 2483704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases].
    Kawai Y; Shiomi T; Ono H; Katagiri H; Uchida R; Sugisaki N; Watanabe K
    Rinsho Byori; 1994 Jan; 42(1):57-62. PubMed ID: 8107284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.
    Gadducci A; Marrai R; Baicchi U; Gagetti O; Facchini V; Genazzani AR
    Gynecol Oncol; 1996 May; 61(2):215-7. PubMed ID: 8626135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
    Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
    Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
    Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
    Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hormone replacement therapy (17 beta-OH estradiol and medroxyprogesterone acetate) on plasma concentration of prothrombin fragment F1+2 and thrombin-antithrombin III complex in postmenopausal woman.
    Ciepłluch R; Czestochowska E
    Acta Haematol Pol; 1996; 27(1):21-5. PubMed ID: 8629439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.